Solid Biosciences Inc Forward P/E
What is the Forward P/E of Solid Biosciences Inc?
The Forward P/E of Solid Biosciences Inc is -0.58
What is the definition of Forward P/E?
Forward price to earnings ratio is the ratio of a company’s stock price to the company’s estimated earnings per share for the next twelve months.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Forward P/E of companies in the Health Care sector on NASDAQ compared to Solid Biosciences Inc
What does Solid Biosciences Inc do?
solid biosciences (solid) is a cambridge, ma based biotech company singularly focused on developing treatments and cures for duchenne muscular dystrophy (dmd). solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of dmd.
Companies with forward p/e similar to Solid Biosciences Inc
- Checkpoint Therapeutics Inc has Forward P/E of -0.63
- Brainstorm Cell Therapeutics has Forward P/E of -0.62
- Fortress Biotech Inc has Forward P/E of -0.61
- Moleculin Biotech Inc has Forward P/E of -0.61
- Clean Diesel Technologies has Forward P/E of -0.60
- BeyondSpring Inc has Forward P/E of -0.59
- Solid Biosciences Inc has Forward P/E of -0.58
- Aethlon Medical Inc has Forward P/E of -0.57
- Petroteq has Forward P/E of -0.57
- Kezar Life Sciences Inc has Forward P/E of -0.57
- Trevena Inc has Forward P/E of -0.57
- Seres Therapeutics Inc has Forward P/E of -0.57
- AwoX SA has Forward P/E of -0.56